Abstract
Disease: Scrapie of sheep and goats, transmissible mink encephalopathy, chronic wasting disease of captive mule deer and elk, and the human diseases kuru, Creutzfeldt-Jakob, and Gerstmann-Straussler syndrome.
Etiologic Agent: Nature unknown.
Source: Unknown.
Clinical Manifestations: Insidious onset with neurologic abnormalities progressing to dementia, listlessness, emaciation, and death.
Pathology: Limited to one organ, the brain; all cases exhibit status spongiosus, neuronal loss, and astrogliosis. The occurrence of amyloid plaques is observed in kuru and Gerstmann-Straussler syndrome and a few cases of Creutzfeldt-Jakob disease.
Laboratory Diagnosis: Primarily based on clinical signs, postmortem neuropathology, transmission studies, and presence of SAF and PrP in brain extracts.
Epidemiology: Scrapie and Creutzfeldt-Jakob disease occur worldwide. The other diseases are focal and all can occur in a familial manner.
Treatment: None known.
Prevention and Control: None known.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literature Cited
Alper, T., D. A. Haig, and M. C. Clark. 1966. The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun. 22: 278–284.
Alper, T., W. A. Cramp, D. A. Haig, and M. C. Clark. 1967. Does the agent of scrapie replicate without nucleic acid? Nature 214: 764–766.
Alper, T., and D. A. Haig. 1968. Protection by anoxia of the scrapie agent and some DNA and RNA viruses irradiated as dry preparations. J. Gen. Virol. 3: 157–166.
Alper, T., D. A. Haig, and M. C. Clark. 1978. The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J. Gen. Virol. 41: 503–516.
Alpers, M. P. 1968, Kuru: implications of its transmissibil- ity for the interpretation of its changing epidemiologic pattern, p. 234–251. InCentral nervous system, Vol. 9. International Academy of Pathology, Baltimore.
Alpers, M. P. 1979. Epidemiology and ecology of kuru. p. 67–90. InS. B. Prusiner, and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
American Association of Tissue Banks. 1984. Standards for tissue banking. American Association of Tissue Banks, Arlington, VA.
Amyx, H. L., C. J. Gibbs, Jr., D. C. Gajdusek, and W. E. Greer. 1981. Absence of vertical transmission of subacute spongiform viral encephalopathies in experimental primates. Proc. Soc. Exp. Biol. Med. 166: 469–471.
Asher, D. M., R. T. Yanagihara, N. G. Rogers, C. J. Gibbs, Jr., and D. C. Gajdusek. 1979. Studies of the viruses of spongiform encephalopathies in cell culture, p. 235–242. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 2. Academic Press, New York.
Asher, D. M., C. L. Masters, D. C. Gajdusek, and C. J. Gibbs, Jr. 1983. Familiar spongiform encephalopathies, p. 273–291. InS. S. Kety, L. P. Rowland, R. L. Sidman, and S. W. Mattkysse (ed.), Genetics of neurological and psychiatric disorders. Raven Press, New York.
Asher, D. M., C. J. Gibbs, Jr., and D. C. Gajdusek. 1986. Slow viral infections: safe handling of the agents of subacute spongiform encephalopathies, p. 59–71. InB. M. Miller (ed.), Laboratory safety: principles and practices. American Society for Microbiology, Washington, D.C.
Baker, H. F., R. M. Ridley, and T. J. Crow. 1985. Experimental transmission of an autosomal dominant spongiform encephalopathy: does the infectious asgent originate in the human genome ? Br. Med. J. 291: 299–302.
Ball, M. J. 1980. Features of Creutzfeldt-Jakob disease in brains of patients with familial dementia of Alzheimer type. Can. J. Neurol. Sci. 7: 51–57.
Barringer, J. P., D. C. Gajudsek, C. J. Gibbs, Jr., C. L. Masters, W. E. Stein, and R. D. Terry. 1980. Transmissible dementias: current problems in tissue handling. Neurology 30: 302–303.
Barry, R. A., and S. B. Prusiner. 1986. Monoclonal antibodies to the cellular and scrapie prion protein. J. Infect. Dis. 154: 518–521.
Barry, R. A., M. P. McKinley, P. E. Bendheim, G. K. Lewis, S. J. De Armond, and S. B. Prusiner. 1985. Antibodies to the scrapie protein decorate prion rods. J. Immunol. 135: 603–613.
Beck, E., P. M. Daniel, and H. B. Parry. 1964. Degeneration of the cerebellar and hypothalamic neurohypophysial systems in sheep with scrapie; and its relationship to human system degenerations. Brain 87: 153–176.
Beck, E., P. M. Daniel, M. Alpers, D. C. Gajdusek, and C. J. Gibbs, Jr. 1966. Experimental “kuru” in chimpanzees: a pathological report. Lancet 2: 1056–1059.
Beck, E., P. M. Daniel, W. B. Matthews, D. L. Stevens, M. P. Alpers, D. M. Asher, D. C. Gajdusek, and C. J. Gibbs, Jr. 1969. Creutzfeldt-Jakob disease: the neuropathology of a transmission experiment. Brain 92: 699–716.
Beck, E., P. M. Daniel, D. C. Gajdusek, and C. J. Gibbs, Jr. 1973. Experimental kuru in the chimpanzee: a neuro- pathological study. Brain 96: 441–442.
Beck, E., and P. M. Daniel, 1979. Kuru and Creutzfeldt- Jakob disease: neuropathological lesions and their significance. p. 253–270. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Bellinger-Kawahara, C., J. E. Cleaver, T. O. Diener, and S. B. Prusiner. 1987. Purified scrapie prions resist inactivation by UV irradiation. J. Virol. 61: 159–166.
Bendheim, P. E., R. A. Barry, S. J. De Armond, D. P. Stites, and S. B. Prusiner. 1984. Antibodies to a scrapie prion protein. Nature 310: 418–421.
Bendheim, P. E., J. M. Bockman, M. P. McKinley, D. T. Kingsbury, and S. B. Prusiner. 1985. Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants. Proc. Natl. Acad. Sci. USA 82: 997–1001.
Bernoulli, C. C., J. Siegfried, G. Baumgartner, F. Regli, T. Rabinowicz, D. C. Gajdusek, and C. J. Gibbs, Jr. 1977. Danger of accidental person to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1: 478–479.
Bernoulli, C. C., C. L. Masters, D. C. Gajdusek, C. J. Gibbs, Jr., and J. O. Harris. 1979. Early clinical features of Creutzfeldt-Jakob disease (subacute spongiform encephalopathy). p. 229–252. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York. Bertrand, J., H. Carre, and F. Leucam. 1937. La tremblante du mouton (recherches histo-pathologiques). Ann. Anat. Pathol. 14: 565–586.
Besnoit, C. 1899. La tremblante ou nevrite peripherique enzootique du mouton. Rev. Vet. Toulouse 24:265–277, 333–343.
Bock, G. and J. Marsh (ed.) Novel infectious agents and the central nervous system. CIBA Foundation Symposium 135. John Wiley and Sons, Chichester. Bockman, J. M., D. T. Kingsbury, M. P. McKinley, P. E. Bendheim, and S. B. Prusiner. 1985. Creutzfeldt-Jakob disease protein in human brains. N. Engl. J. Med. 312:73–78.
Bode, L., M. Pocchiari, H. Gelderbloom, and H. Diringer. 1985. Characterization of antisera against scrapie-asso- ciated fibrils (SAF) from affected hamster and cross reactivity with SAF from scrapie-affected mice and patients with Creutzfeldt-Jakob disease. J. Gen. Virol. 66: 2471–2478.
Boellaard, J. W., and W. Schlote. 1980. Subakute spongi- forme Encephalopathie mit multiformer plaquebildung. “Eigenartige familiar-hereditare Krankheit des Zen- tralnervensystems [spino-cerebellare Atrophie mit Demenz, Plaques und plaqueahnlichen Ablagerungen im Klein- und Grosshirn” (Gerstmann, Straussler, Scheinker)]. Acta Neuropathol. (Berl.) 49: 205–212.
Bolton, D. C., M. P. McKinley, and S. B. Prusiner. 1982. Identification of a protein that purifies with the scrapie prion. Science 218: 1309–1311.
Bolton, D. C., R. K. Meyer, and S. B. Prusiner. 1985. Scrapie PrP 27–30 is a sialoglycoprotein. J. Virol. 53: 596–606.
Borras, M. T., D. T. Kingsbury, D. C. Gajdusek, and C. J. Gibbs, Jr. 1982. Inability to transmit scrapie by transfec- tion of mouse embryo cells in vitro. J. Gen. Virol. 58: 263–271.
Borras, T., and C. J. Gibbs, Jr. 1986. Molecular hybridization studies of scrapie brain nucleic acids. 1. Search for specific DNA sequences. Arch. Virol. 88:67–78. Braig, H. R., and H. Diringer. 1985. Scrapie: concept of a virus-induced amyloidosis of the brain. EMBO J. 4: 2309–2312.
Brotherson, J. G., C. C. Renwick, J. T. Stamp, I. Zlotnick, and I. H. Patterson. 1968. Spread of scrapie by contact to goats and sheep. J. Comp. Pathol. 8: 9–17.
Brown, P. 1980. An epidemiologic critique of Creutzfeldt- Jakob disease. Epidemiol. Rev. 2: 113–135.
Brown, P. 1985. Virus sterility for human growth hormone. Lancet 2: 729–730.
Brown, P., 1988. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatiogenic cases. In: Novel infectious agents and the central nervous system. CIBA Foundation Symposium 135. In press.
Brown, P., F. Cathala, D. Sadowsky, and D. C. Gajdusek. 1979. Creutzfeldt-Jakob disease in France. III. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann. Neurol. 6: 430–437.
Brown, P., R. G. Rohwer, E. M. Green, and D. C. Gajdusek. 1982. Effect of chemicals, heat and histopathologic processing on high infectivity hamster-adapted scrapie virus. J. Infect. Dis. 145: 683–687.
Brown, P., P. Rogers-Johnson, D. C. Gajdusek, and C. J. Gibbs, Jr. 1984. Creutzfeldt-Jakob disease of long duration: clinical pathological characteristics, transmissibil- ity and differential diagnosis. Ann. Neurol. 16: 295–304.
Brown, P., D. C. Gajdusek, C. J. Gibbs, Jr., and D. M. Asher. 1985. Potential epidemic of Creutzfeldt- Jakob disease from human growth hormone therapy. N. Engl. J. Med. 313: 728–731.
Brown, P., R. G. Rohwer, and D. C. Gajdusek. 1986a. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J. Infect. Dis. 153: 1145–1148.
Brown, P., M. Coker-Vann, K. Pomeray, M. Franko, D. M. Asher, C. J. Gibbs, Jr., and D. C. Gajdusek. 1986b. Diagnosis of Creutzefeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N. Engl. J. Med. 314: 547–551.
Bruce, M. E. 1985. Agent replication dynamics in a long incubation period model of mouse scrapie. J. Gen. Virol. 66: 2517–2522.
Bruce, M. E., and A. G. Dickinson. 1979. Biological stability of different classes of scrapie agent, p. 71–86. InS. B. Prusiner, and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Bruce, M. E., and A. G. Dickinson. 1985. Genetic control of amyloid plaque production and incubation period in scrapie-infected mice. J. Neuropathol. Exp. Neurol. 44: 285–294.
Bruce, M. E., and A. G. Dickinson. 1987. Biological evidence that scrapie agent has an independent genome. J. Gen. Virol. 68: 79 - 89.
Bruce, M. E., and H. Fraser. 1975. Amyloid plaques in the brain of mice infected with scrapie: morphological variation and staining properties. Neuropathol. Appl. Neuro- biol. 1: 189–202.
Bruce, M. E., and H. Fraser. 1981. Effect of route of infection on the frequency and distribution of cerebral amyloid plaques in scrapie mice. Neuropathol. Appl. Neuro- biol. 7: 289–298.
Bruce, M. E., and H. Fraser. 1982. Focal and asymmetrical vacuolar lesions in the brains of mice infected with certain strains of scrapie. Acta Neuropathol. (Berl.) 58: 133–140.
Bruce, M. E., A. G. Dickinson, and H. Fraser. 1976. Cerebral amyloidosis in scrapie in the mouse; effect of agent strain and mouse genotype. Neuropathol. Appl. Neuro- biol. 2: 471–478.
Burger, D., and G. R. Hartsough. 1965. Encephalopathy of mink. II. Experimental and natural transmission. J. Infect. Dis. 115: 393–399.
Burger, L. J., A. J. Rowan, and E. S. Goldensohn. 1972. Creutzfeldt-Jakob disease: an electroencephalographic study. Arch. Neurol. 26: 428–433.
Buyukmihci, N., F. Goering-Harmon, and R. F. Marsh. 1983. Neural pathogenesis of experimental scrapie after intraocular inoculation of hamsters. Exp. Neurol. 81: 396–406.
Carlson, G. A., D. T. Kingsbury, P. A. Goodman, S. Coleman, S. T. Marshall, S. De Armond, D. Westaway, and S. B. Prusiner. 1986. Prion protein and scrapie incubation time genes are linked. Cell 46: 503–511.
Carp, R. I. 1981. Transmission of scrapie by the oral route: effect of gingival scarification. Lancet 1: 120–171.
Carp, R. I., S. M. Callahan, E. A. Sersen, and R. C. Moretz, 1984. Preclinical changes in weight of scrapie- infected mice as a function of scrapie agent-mouse strain combination. Intervirology 21: 61–69.
Carp, R. I., P. A. Merz, R. C. Moretz, R. A. Somerville, S. M. Callahan, and H. M. Wisniewski. 1985a. Biological properties of scrapie, an unconventional slow virus, p. 425–463. InK. Maramorosch, and J. J. McKelvey (ed.), Sub viral pathogens of plants and animals: viroids and prions. Academic Press, New York.
Carp, R. I., P. A. Merz, R. J. Kascsak, G. S. Merz, and H. M. Wisniewski. 1985b. Nature of the scrapie agent: current status of facts and hypotheses. J. Gen. Virol. 67: 1357–1368.
Carp, R. I., R. C. Moretz, M. Natelli, and A. G. Dickinson. 1987. Genetic control of scrapie: incubation period and plaque formation in I mice. J. Gen. Virol. 68: 401–407.
Cathala, F., J. Chatelain, P. Brown, M. Dumas, and D. C. Gajdusek. 1980. Familial Creutzfeldt-Jakob disease: autosomal dominance in 14 members over 3 generations. J. Neurol. Sci. 47: 343–351.
Cauvet, J. 1854. Sur la tremblante. J. Vet. Midi 7: 441–448.
Chandler, R. L. 1961. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1: 1378–1379.
Chandler, R. L. 1963. Experimental scrapie in the mouse. Res. Vet. Sci. 4: 276–285.
Chandler, R. L., and J. Fisher. 1963. Experimental transmission of scrapie to rats. Lancet 2: 1165.
Chatelain, J., F. Cathala, P. Brown, S. Ra-Harrison, L. Court, and D. C. Gajdusek. 1981. Epidemiologic comparisons between Creutzfeldt-Jakob disease and scrapie in France during the 12-year period 1968-1979. J. Neurol. Sci. 51: 329–337.
Chatigny, M. A., and S. B. Prusiner. 1980. Biohazards of investigations on the transmissible spongiform encephalopathies. Rev. Infect. Dis. 2: 713–724.
Chelle, P. L. 1942. Un cas de tremblante chez la chevre. Bull. Acad. Vet. Fr. 15: 294–295.
Chesebro, B., R. Race, K. Wehrly, J. Nishio, M. Bloom, D. Lechner, S. Bergstrom, K. Robbins, L. Mayer, J. M. Keith, C. Garon, and A. Haase. 1985. Identification of scrapie prion protein specific mRNA in scrapie-infected and uninfected brain. Nature 315: 331–333.
Chiofala, N., A. Fuentes, and S. Galvez. 1980. Serial EEG findings in 27 cases of Creutzfeldt-Jakob disease. Arch. Neurol. 37: 143–145.
Cho, H. J. 1980a. Requirement of a protein component for scrapie infectivity. Intervirology 14: 213–216.
Cho, H. J. 1980b. Inactivation of the scrapie agent by pro- nase. Can. J. Comp. Med. 47: 313–320.
Cho, H. J. 1986. Antibody to scrapie-associated fibril protein identifies a cellular antigen. J. Gen. Virol. 67: 243–252.
Claridge, J. Extract from a general view of agriculture in the county of Dorset; with observations on the means of its improvement. Bath Papers 7: 66–73; 1795.
Clark, M. C. 1979. Infection of cell cultures with scrapie agent, p. 225–233. InS. B. Prusiner and W. J. Hadlow, (ed.), Slow transmissibile diseases of the nervous system, Vol. 2. Academic Press, New York.
Clark, M. C., and D. A. Haig. 1970. Multiplication of scrapie agent in cell culture. Res. Vet. Sci. 11: 500.
Clark, M. C., and D. A. Haig. 1971a. An attempt to determine whether maternal transmission of scrapie occurs in mice. Br. Vet. J. 127: 32–34.
Clark, M. C. and D. A. Haig. 1971b. Multiplication of scrapie agent in mouse spleen. Res. Vet. Sci. 12: 195–197.
Clark, M. C., and G. C. Millson. 1976a. The membrane localization of scrapie infectivity. J. Gen. Virol. 31: 441–445.
Clark, M. C., and G. C. Millson. 1976b. Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature 262: 144–145.
Cole, S., and R. H. Kimberlin. 1985. Pathogenesis of mouse scrapie: dynamics of vacuolation in brain and spinal cord after intraperitoneal infection. Neuropathol. Appl. Neurobiol. 11: 213–227.
Collis, S. C., and R. H. Kimberlin. 1985. Long-term persistence of scrapie infection in mouse spleens in the absence of clinical disease. FEMS Microbiol. Lett. 29: 111–114.
Court, L., and F. Cathala. (ed.). 1983. Virus non conventional et affections du systeme nerveure central, Vol. 1, p. 528. Masson, Paris.
Creutzfeldt, H. G. 1920. Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z. Gesamte Neurol. 57: 1–18.
Creutzfeldt, H. G. 1921. Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. p. 1-48. InF. Nissl and A. Alzheimer (ed.), Histologische und Histo- pathologische Arbeiten uber die Grosshirnrinde, Vol. 6. Gustav Fischer, Jena, G. D. R.
Cuille, J., and P. L. Chelle. 1936. La maladie dite tremblante du mouton est-elle inoculable. C. R. Acad. Sci. Paris 205: 1552–1554.
Czub, M., N. R. Braig, H. Blade, and H. Diringer, 1986a. The major protein of SAF is absent from spleen and thus not an essential part of the scrapie agent. Arch. Virol. 91: 383–386.
Czub, M., H. R. Braig, and H. Diringer. 1986b. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titers and scrapie associated fibrils in brains of hamsters infected intraperitone- ally. J. Gen. Virol. 67: 2005–2009.
De Armond, S. J., M. P. McKinley, R. A. Barry, M. B. Braunfeld, J. R. McColloch, and S. B. Prusiner. 1985. Identification of prion amyloid filaments in scrapie-in- fected brain. Cell 41: 221–235.
Dickinson, A. G. 1975. Host-pathogen interactions in scrapie. Genetics 79: 387–395.
Dickinson, A. G. 1976. Scrapie in sheep and goats, p. 209–241. InR. H. Kimberlin (ed.), Slow virus diseases of animals and man. North-Holland, Amsterdam.
Dickinson, A. G., and H. Fraser. 1972. Scrapie: effect of Dh gene on the incubation period of extraneurally injected agent. Heredity 29: 91–93.
Dickinson, A. G., and H. Fraser. 1977. Scrapie pathogenesis in inbred mice: an assessment of host control and response involving many strains of agent, p. 3–14. InV. ter Meulen and M. Katz (ed.), Slow virus infections of the central nervous system. Springer-Verlag, New York.
Dickinson, A. G., and H. Fraser. 1979. An assessment of the genetics of scrapie in sheep and mice. p. 367–385. InS. B. Prusiner, and W. J. Hadlow, (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Dickinson, A. G., and V. M. H. Meikle. 1969. A comparison of some biological characteristics of the mouse-pas- saged scrapie agents, 22A and ME7. Genet. Res. 13: 213–225.
Dickinson, A. G., and V. M. H. Meikle, 1971. Host-geno- type and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol. Gen. Genet. 112: 73–79.
Dickinson, A. G., and G. Outram. 1979. The scrapie replication-site hypothesis and its implication for pathogenesis. p. 13–31. InS. B. Prusiner, and W. J. Hadlow (ed.), Slow transmissible diseases in the nervous system, Vol. 2. Academic Press, New York.
Dickinson, A. G., and G. W. Outram. 1983. Operational limitations in the characterization of the infective units of scrapie, p. 3–16. InL. A. Court, and F. Cathala, (ed.), Virus non conventionnels et affections du systeme nerveux central. Masson, Paris.
Dickinson, A. G., and D. M. Taylor. 1978. Resistance of scrapie agent to decontamination. N. Engl. J. Med. 299: 1413–1414.
Dickinson A. G., V. M. H. Meikle, and H. Fraser. 1969. Genetical control of the concentration of ME7 scrapie agent in the brain of mice. J. Comp. Pathol. 79: 15–22.
Dickinson, A. G., J. T. Stamp, and C. C. Renwick. 1974. Maternal and lateral transmission of scrapie in sheep. J. Comp. Pathol. 84: 19–25.
Dickinson, A. G., H. Fraser, L. McConnell, G. W. Outram, D. I. Sales, and D. M. Taylor. 1975. Extraneural competition between different scrapie agent leading to loss of infectivity. Nature 253: 556.
Dickinson, A. G., H. Fraser, and G. W. Outram. 1976. Scrapie incubation time can exceed natural lifespan. Nature 256: 732–733.
Dickinson, A. G., M. E. Bruce, H. Fraser, and R. H. Kimberlin. 1984. Scrapie strain differences: the implication of stability and mutation, p. 105–118. InJ. Tateishi (ed.), Proceedings of Workshop on Slow Transmissible Diseases. Japanese Ministry of Health and Welfare, Tokyo.
Diener, T. O., M. P. McKinley, and S. B. Prusiner. 1982. Viroids and prions. Proc. Natl. Acad. Sci. USA 79: 5220–5224.
Diringer, H. 1984. Sustained viremia in experimental hamster scrapie. Arch. Virol. 82: 105–109.
Diringer, H., H. Gelderblom, H. Hilmert, M. Ozel, C. Edelbluth, and R. H. Kimberlin. 1983a. Scrapie infectivity, fibrils and low molecular weight protein. Nature 306: 476–478.
Diringer, H., H. Hilmert, D. Simon, E. Werner, and B. Ehlers. 1983b. Toward purification of the scrapie agent. Eur. J. Biochem. 134: 555–560.
Diringer, H, H. C. Rahn, and L. Bode. 1984. Antibodies to protein of scrapie associated fibrils. Lancet 2: 345.
Duffy, P., J. Wolf, G. Collins, A. Devoe, B. Steeten, and D. Cowen. 1974. Possible person to person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 290: 692–693.
Eklund, C. M., W. J. Hadlow, and R. C. Kennedy. 1963. Some properties of the scrapie agent and its behavior in mice. Proc. Soc. Exp. Biol. Med. 112: 974–979.
Ferber, R. A., S. L. Wiesenfeld, R. P. Roos, A. R. Borowich, C. J. Gibbs, Jr., and D. C. Gajdusek. 1974. Familial Creutzfeldt-Jakob disease: transmission of the familial disease to primates, p. 308–380. InA. Subirana, J. M. Espadaler, and E. H. Burrows (ed.), International Congress Series 319. Excerpta Medica, Amsterdam.
Flament-Durand, J., and A. M. Couck. 1979. Spongiform alterations in brain biopsies of presenile dementia. Acta Neuropathol. (Berl.) 46: 159–162.
Fraser, H. 1976. The pathology of natural and experimental scrapie, p. 267–305. InR. H. Kimberlin (ed.), Slow virus diseases of animals and man. North-Holland, Amsterdam.
Fraser, H. 1979. Neuropathology of scrapie, the precision of the lesions and their diversity, p. 387–406. InS. B. Prusiner. and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Fraser, H. 1981. Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway. Nature 294: 149–150.
Fraser, H. 1983. A survey of primary transmissions of scrapie and rida to mice. p. 34–46. InL. A. Court, and F. Cathala (ed.), Virus non conventionnels et affections du systeme nerveux central. Masson, Paris.
Fraser, H., and M. E. Bruce. 1973. Argyrophlic plaques in mice inoculated with scrapie from particular sources. Lancet 1: 617–618.
Fraser, H., and A. G. Dickinson. 1970. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226: 462–463.
Fraser, H., and A. G. Dickinson. 1973. Scrapie in mice: agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol. 83: 29–40.
Fraser, H., and A. G. Dickinson. 1978. Studies of the lym- phoreticular system in the pathogenesis of scrapie: role of spleen and thymus. J. Comp. Pathol. 88: 563–573.
Fraser, H., and A. G. Dickinson. 1985. Targeting of scrapie lesions and spread of agent via the retino-tectal projection. Brain Res. 346: 32–41.
Gajdusek, D. C. 1977. Unconventional viruses and the origin and disappearance of kuru. Science 197: 943–960.
Gajdusek, D. C. 1985. Unconventional viruses causing subacute spongiform encephalopathies, p. 1519–1557. InB. N. Fields (ed.), Virology. Raven Press, New York.
Gajdusek, D. C., and V. Zigas. 1957. Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of “kuru” in the native population. N. Engl. J. Med. 257: 974–978.
Gajdusek, D. C., and V. Zigas. 1959. Kuru: clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the eastern highlands of New Guinea. Am. J. Med. 26: 442–469.
Gajdusek, D. C., C. J. Gibbs, Jr., and M. Alpers. 1966. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209: 794–796.
Gajdusek, D. C., C. J. Gibbs, Jr., G. Collins, and R. Traub. 1976. Survival of Creutzfeldt-Jakob disease in Formol fixed brain tissue. N. Engl. J. Med. 294: 553.
German, T. L., and R. F. Marsh. 1983. The scrapie agent: a unique self-replicating pathogen, p. 111–121. InF. E. Hahn (ed.), Progress in molecular and subcellular biology, Vol. 8. Springer-Verlag, Berlin.
Gerstmann, J., E. Straussler, and J. Scheinker. 1936. Uber eine eigenartige hereditarfamiliare Eikrankungen des Zentralnervensystems. Z Neurol. 159: 736–762.
Gibbons, R. A., and G. D. Hunter. 1967. Nature of the scrapie agent. Nature 215: 1041–1043.
Gibbs, C. J. Jr., D. C. Gajdusek, D. M. Asher, M. P. Alpers, E. Beck, P. M. Daniel, and W. B. Matthews. 1968. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 161: 388–389.
Gibbs, C. J. Jr., D. C. Gajdusek, and R. Lataijet. 1978. Unusual resistance to UV and ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease and scrapie (unconventional viruses). Proc. Natl. Acad. Sci. USA 75: 6268–6270.
Gibbs, C. J. Jr., D. C. Gajdusek, and H. Amyx. 1979. Strain variation in the viruses of Creutzfeldt-Jakob disease and kuru. p. 87–110. InS. B. Prusiner, and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 2. Academic Press, New York.
Gibbs, C. J. Jr., H. L. Amyx, A. Bacote, C. L. Masters, and D. C. Gajdusek. 1980. Oral transmission of kuru, Creutzfeldt-Jakob disease and scrapie to non-human primates. J. Infect. Dis. 142: 205–208.
Gibbs, C. J. Jr., A. Joy, R. Heffner, M. Franko, M. Miyaszki, D. M. Asher, J. E. Parisi, P. B. Brown, and D. C. Gajdusek. 1985. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N. Engl. J. Med. 313: 734–738.
Gibson, P. E., T. M. Bell, and E. J. Field. 1972. Failure of the scrapie agent to replicate in L51784 mouse leukaemic cells. Res. Vet. Sci. 13: 95–96.
Gibson, P. H., R. A. Somerville, H. Fraser, J. D. Foster, and R. H. Kimberlin. 1987. Scrapie associated fibrils in the diagnosis of scrapie in sheep. Vet. Res. Feb. 7, 125–127.
Girard, J. 1829, 1830. Notice sur quelques maladies peu connues des betes a laine. Rec. Med. Vet. 6:674–683;’ 7:26–39, 65–76.
Glass, R. M. 1963. Cannabilism in the Kuru region. Department of Public Health, Papua, New Guinea.
Gorde, J. M., J. Tamalet, M. Toga, and J. Bert. 1982. Changes in the nigrostriatal system following microinjection of an unconventional agent. Brain Res. 240: 87–93.
Gordon, W. S. 1946. Louping-ill, tick borne fever and scrapie. Vet. Res. 58: 516–525.
Griffith, J. S. 1967. Self-replication and scrapie. Nature 215: 1043–1044.
Hadlow, W. J. 1959. Scrapie and kuru. Lancet 2: 289–290.
Hadlow, W. J., C. M. Eklund, R. C. Kennedy, T. A. Jackson, H. W. Whitford, and C. C. Boyle. 1974. Course of experimental scrapie virus in the goat. J. Infect. Dis. 129: 559–567.
Hadlow, W. J., R. E. Race, C. Kennedy, C., and C. M. Eklund. 1979. Natural infection of sheep with scrapie virus, p. 3–12. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 2. Academic Press, New York.
Hadlow, W. J., R. C. Kennedy, and R. E. Race. 1982. Natural infection of Suffolk sheep with scrapie virus. J. Infect. Dis. 146: 657–664.
Haig, D. A., M. C. Clark, E. Blum, and T. Alper. 1969. Further studies on the inactivation of the scrapie agent by ultraviolet light. J. Gen. Virol. 5: 455–457.
Haltia, M., J. Kovanen, H. van Crevel, G. Bots, G. Th. A. M. Bots, and I. Stefanko. 1979. Familial Creutzfeldt- Jakob disease. J. Neurol. Sci. 42: 381–389.
Harrington, M. G., C. R. Merril, D. M. Asher, and D. C. Gajdusek. 1986. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N. Engl. J. Med. 315: 279–283.
Harris, T. 1985. Persistently puzzling prions. Nature 315: 278.
Hartsough, G. R., and D. Burger. 1965. Encephalopathy in mink. I. Epizoological and clinical observations. J. Infect. Dis. 115: 387–392.
Hikita, K., J. Tateishi, and H. Nagara. 1985. Morphogenesis of amyloid plaques in mice with Creutzfeldt-Jakob disease. Acta Neuropathol. (Berl.) 68: 138–144.
Hilmert, H., and H. Diringer. 1984. A rapid and efficient method to enich SAF-protein from scrapie brains of hamsters. Biosci. Rep. 4: 165–170.
Hintz, R. M., M. MacGillivay, A. Joy, and R. Tintner. 1985. Fatal degenerative neurological disease in patients who received pituitary derived human growth hormone. Morbid. Mortal. Weekly Rep. 34: 359–366.
Hope, J., and R. H. Kimberlin. 1987. The molecular biology of scrapie: the last two years. TINS 10: 149–151.
Hope, J., L. J. D. Morton, C. F. Faraquhar, G. Multhaup, K. Beyreuther, and R. H. Kimberlin. 1986. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 5: 2591–2597.
Hornabrook, R. W. 1979. Kuru and clinical neurology, p. 37–66. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Hourrigan, J., A. Klingsporn, W. W. Clark, and M. de-Camp. 1979. Epidemiology of scrapie in the United States, p. 331–356. InS. B. Prusiner, and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Hunter, G. D., S. C. Collis, G. C. Millson, and R. H. Kimberlin. 1976. Search for scrapie-specific RNA and attempts to detect an infectious DNA or RNA. J. Gen. Virol. 32: 157–162.
Jakob, A. 1921. Uber eigenartige Erkankungen des Zen- tralnervensystems mit bemerkensweitem anatomischen Befunde (spastische Pseudosclerose-Encephalomyelo- pathie mit disseminierten Degenerationsheiden). Dtsch. Z. Nervenheilkd. 70: 132–146.
Johnson, R. T. 1982. The novel nature of scrapie. TINS 5: 413–415.
Journal of the House of Commons. 1755. 27:87.
Kascsak, R. J., R. Rubenstein, P. A. Merz, R. I. Carp, H. M. Wisniewski, and H. Diringer. 1985. Biochemical differences among scrapie associated fibrils support the biological diversity of scrapie agents. J. Gen. Virol. 66: 1715–1722.
Kascsak, R. J., R. Rubenstein, P. A. Merz, R. I. Carp, N. K. Robakis, and H. M. Wisniewski. 1986. Immunological comparison of scrapie associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 59: 676–683.
Kascsak, R. J., R. Rubenstein, P. A. Merz, M. Tomma- DeMasi, R. Fersko, R. I. Carp, H. M. Wisniewski, and H. Diringer. 1987a. Mouse polyclonal and monoclonal antibody to SAF (PrP) protein. J. Virol. (Dec. 1987 ).
Kascsak, R. J., R. Rubenstein, P. A. Merz, R. I. Carp, and P. Brown. 1987b. Monoclonal antibody for detection of human unconventional slow virus diseases. (Submitted. )
Kidson, C., M. C. Moreau, D. M. Asher, P.W. Brown, H. G. Coon, D. C. Gajdusek, and C. J. Gibbs, Jr. 1978. Cell fusion induced by scrapie and Creutzfeldt-Jakob virus-infected preparations. Proc. Natl. Acad. Sci. USA 75: 2969–2971.
Kim, Y. S., R. I. Carp, S. M. Callahan, and H. M. Wisniewski. 1987a. Clinical course of three scrapie strains in mice injected stereotaxically in different brain regions. J. Gen. Virol. 68: 695–702.
Kim, Y. S., R. I. Carp, S. M. Callahan, and H. M. Wisniewski. 1987b. Scrapie-induced obesity in mice. J. Infect. Dis. 156: 402–405.
Kimberlin, R. H. (ed). 1976. Slow virus diseases of animals and man. Elsevier, New York.
Kimberlin, R. H. 1979. Aetiology and genetic control of natural scrapie. Nature 278: 303–304.
Kimberlin, R. H. 1981. Scrapie. Br. Vet. J. 137: 105–112.
Kimberlin, R. H. 1982a. Reflections on the nature of scrapie agent. TIBS 7: 392–394.
Kimberlin, R. H. 1982b. Scrapie agent: prions or virinos? Nature 297: 107–108.
Kimberlin, R. H. 1984. Scrapie: the diseases and the infectious agent. TIBS 7: 312–316.
Kimberlin, R. H. 1986. Scrapie: how much do we really understand? Neuropathol. Appl. Neurobiol. 12: 131–147.
Kimberlin, R. H., S. Cole, and C. A. Walker. 1987. Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microbiol. Pathogen. 2: 405–415.
Kimberlin, R. H., S. M. Hall, and C. A. Walker. 1983. Pathogenesis of mouse scrapie: evidence for direct neural spread of infection to the CNS after injection of sciatic nerve. J. Neurol. Sci. 61: 315–325.
Kimberlin, R. H., and C. A. Walker. 1977. Characteristics of a short incubation model of scrapie in the golden hamster. J. Gen. Virol. 34: 295–304.
Kimberlin, R. H., and C. A. Walker. 1978a. Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J. Gen. Virol. 39: 487–496.
Kimberlin, R. H., and C. A. Walker. 1978b. Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titers and dose-response curves. J. Comp. Pathol. 88: 39–47.
Kimberlin, R. H., and C. A. Walker. 1979. Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain. J. Comp. Pathol. 89: 551–562.
Kimberlin, R. H., and C. A. Walker. 1980. Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J. Gen. Virol. 51: 183–187.
Kimberlin, R. H., and C. A. Walker. 1982. Pathogenesis of mouse scrapie: patterns of agent replication in different parts of the CNS following intraperitoneal infection. J. R. Soc. Med. 75: 618–624.
Kimberlin, R. H., and C. A. Walker. 1983. Invasion of the CNS by scrapie agent and its spread to different parts of the brain, p. 17–33. InL. A. Court and F. Cathala (ed.), Virus non conventionnels et affections du systeme nerveux central. Masson, Paris.
Kimberlin, R. H., and C. A. Walker. 1986. Pathogenesis of scrapie (strain 263K) in hamsters infected intracere- brally, intraperitoneally or intraocularly. J. Gen. Virol. 67: 255–263.
Kingsbury, D. T., H. L. Amyx, and C. J. Gibbs, Jr. 1983. Biophysical properties of the Creutzfeldt-Jakob disease agent, p. 125–137. InL. Court and F. Cathala (ed.), Virus non-conventionnels et affections du systeme nerveux central. Masson, Paris.
Kitamoto, T., J. Tateishi, T. Tashima, I. Takeshita, R. A. Barry, S. J. DeAmond, and S. B. Prusiner. 1986. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann. Neuol. 20: 204–208.
Klatzo, I., D. C. Gajdusek, and V. Zigas. 1959. Pathology of kuru. Lab. Invest. 8: 799–847.
Klitzman, R. L., M. P. Alpers, and D. C. Gajdusek. 1985. The natural incubation period of kuru and the episodes of transmission in three clusters of patients. Neuroepi- demiology 3: 3–20.
Koch, T. K., B. O. Berg, S. J. DeArmond, and R. F. Gravina. 1985. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism: possible relation to the administration of cadaveric human growth hormone. N. Engl. J. Med. 313: 731–733.
Kuguhara, S., I. Kanazawa, H. Sasaki, T. Nakanishi, and K. Shimamura. 1983. Gerstmann-Straussler- Scheinker’s disease. Ann. Neurol. 14: 216–225.
Kuroda, Y., C. J. Gibbs, Jr., H. L. Amyx, and D. C. Gajdusek. 1983. Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect. Immun. 41: 159–161.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680–685.
Lampert, P. W., D. C. Gajdusek, and C. J. Gibbs, Jr. 1971. Experimental spongiform encephalopathy (Creutzfeldt- Jakob disease) in chimpanzees. J. Neuropathol. Exp. Neurol. 30: 20–32.
Lampert, P. W., D. C. Gajdusek, and C. J. Gibbs, Jr. 1972. Subacute spongiform virus encephalopathies: scrapie, kuru and Creutzfeldt-Jakob disease. Am. J. Pathol. 68: 626–646.
Lataijet, R. 1979. Inactivation of the agents of scrapie, Creutzfeldt-Jakob disease and kuru by radiations, p. 387–408. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 2. Academic Press, New York.
Lataijet, R., B. Muel, D. A. Haig, M. C. Clark, and T. Alper. 1970. Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature 227: 1341–1343.
Lax, A.J., G. C. Millson, and E. J. Manning. 1983. Involvement of protein in scrapie agent infectivity. Res. Vet. Sci. 34: 155–158.
Liao, Y. C., R. V. Lebo, G. A. Clawson, and E. A. Smuckler. 1986. Human prion protein cDNA: molecular cloning, chromosomal mapping and biological implications. Science 233: 364–367.
Macchi, G., H. L. Abbamondi, G. Di Trapani, and A. Ibriccoli. 1984. On the white matter lesions of the Creutzfeldt-Jakob disease. J. Neurol. Sci. 63: 197–206.
Manuelidis, E. E. 1975. Transmission of Creutzfeldt-Jakob disease from man to guinea pig. Science 190: 571–572.
Manuelidis, E. E. 1985. Presidential address: Creutzfeldt- Jakob disease. J. Neuropathol. Exp. Neurol. 44: 1–17.
Manuelidis, E. E., and L. Manuelidis. 1979. Experiments on maternal transmission of Creutzfeldt-Jakob disease in guinea pigs. Proc. Soc. Exp. Biol. Med. 160: 233–236; 1979.
Manuelidis, E. E., J. Kim, J. N. Angelo, and L. Manuelidis. 1976. Serial propagation of Creutzfeldt-Jakob disease in guinea pigs. Proc. Natl. Acad. Sci. USA 73: 223–227.
Manuelidis, E. E., J. N. Angelo, E. J. Gorgacz, and L. Manuelidis. 1977a. Transmission of Creutzfeldt-Jakob disease to Syrian hamster. Lancet 1: 479.
Manuelidis, E. E., J. N. Angelo, E. J. Gorgacz, J. H. Kim, and L. Manuelidis. 1977b. Experimental Creutzfeldt-Jakob disease transmitted via the eye with infected cornea. N. Engl. J. Med. 296: 1334–1336.
Manuelidis, E. E., E. J. Gorgacz, and L. Manuelidis. 1978a. Viremia in experimental Creutzfeldt-Jakob disease in guinea pigs. Proc. Soc. Exp. Biol. Med. 160: 233–236.
Manuelidis, E. E., E. J. Gorgacz, and L. Manuelidis. 1978b. Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice. Nature 271: 778–779.
Manuelidis, E. E., J. H. Kim, J. R. Mericangas, and L. Manuelidis. 1985. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 2: 896.
Manuelidis, L., and E. E. Manuelidis. 1980. Search for specific DNA’s in Creutzfeldt-Jakob infectious brain fractions using “nick translation.” Virology 109: 435–443.
Manuelidis, L., and E. E. Manuelidis. 1983. Fractionation and infectivity studies in Creutzfeldt-Jakob disease, p. 399–412. InR. Katzman (ed.), Biological aspects of Alzheimer’s disease, Vol. 15. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Manuelidis, L., and E. E. Manuelidis. 1986. Recent developments in scrapie and Creutzfeldt-Jakob disease. Prog. Med. Virol. 33: 78–98.
Manuelidis, L., S. Valley, S., and E. E. Manuelidis. 1985. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants. Proc. Natl. Acad. Sci. USA 82: 4263–4267.
Manuelidis, L., T. Sklaviadis, and E. E. Manuelidis. 1987. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J. 6: 341–347.
Markovits, P., C. Dauthville, D. Dormont, L. Dianoux, and R. Lataijet. 1983. in vitro propagation of the scrapie agent. 1. Transformation of mouse glia and neuroblastoma cells after infection with the mouse-adapted strain C-506. Acta Neuropthol. (Berl.) 60:75–80.
Marsh, R. F., and R. P. Hanson. 1979. On the origin of transmissible mink encephalopathy, p. 451–460. InS. B. Prusiner, and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Marsh, R. F., and R. H. Kimberlin. 1975. Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. J. Infect. Dis. 131: 104–110.
Marsh, R. F., J. S. Semancik, K. C. Medappa, R. P. Hanson, and R. R. Rueckert. 1974. Scrapie and transmissible mink encephalopathy: search for infectious nucleic acid. J. Virol. 13: 993–996.
Masters, C. L., and D. C. Gajdusek. 1982. The spectrum of Creutzfeldt-Jakob disease and the virus-induced subacute spongiform encephalopathies, p. 139–163. InW. T. Smith and J. D. Cavanagh (ed.), Recent advances in neuropathology, Vol. 9. Churchill Livingstone, Edinburgh.
Masters, C. L., and E. P. Richardson, Jr. 1978. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease): the nature and progression of spongiform change. Brain 101: 333–344.
Masters, C. L., J. O. Harris, D. C. Gajdusek, C. J. Gibbs, Jr., C. Bernoulli, and D. M. Asher. 1979. Creutzfeldt- Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann. Neurol. 5: 177–188.
Masters, C. L., D. C. Gajdusek, and C. J. Gibbs, Jr. 1981a. The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer’s disease. Brain 104: 535–558.
Masters, C. L., D. C. Gajdusek, and C. J. Gibbs, Jr. 1981b. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome. Brain 104: 559–588.
Masters, C. L., R. G. Rohwer, M. C. Franko, P. Brown, and D. C. Gajdusek. 1984. The sequential development of spongiform change and gliosis of scrapie in the golden Syrian hamster. J. Neuropathol. Exp. Neurol. 43: 242–252.
Masters, C. L., G. Simms, N. A. Weinman, G. Multhaup, B. L. McDonald, and K. Beyreuther. 1985a. Amyloid plaque core protein in Alzheimer disease and Down Syndrome. Proc. Natl. Acad. Sci. USA 82: 4242–4249.
Masters, C. L., G. Multhaup, G. Simms, J. Pottgiesser, R. N. Martins, and K. Beyreuther. 1985b. Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer’s disease contains the same protein as the amyloid plaque cores and blood vessels. EMBO J. 4: 2759–2763.
Matthews, W. B. 1975. Epidemiology of Creutzfeldt-Jakob disease in England and Wales. J. Neurol. Neurosurg. Psychiatry 38: 210–213.
McKinley, M. P., and S. B. Prusiner. 1986. Biology and structure of scrapie prions. Int. Rev. Neurobiol. 28: 1–57.
McKinley, M. P., F. R. Masiarz, and S. B. Prusiner. 1981. Reversible chemical modification of scrapie agent. Science 214: 1259–1260.
McKinley, M. P., D. C. Bolton, and S. B. Prusiner. 1983a. A protease resistant protein is a structural component of the scrapie prion. Cell 35: 57–62.
McKinley, M. P., F. R. Masiarz, S. T. Isaacs, J. E. Hearst, and S. B. Prusiner. 1983b. Resistance of the scrapie agent to inactivation by psoralens. Photochem. Photo- biol. 37: 539–545.
Merz, P. A., R. A. Somerville, H. M. Wisniewski, and K. Iqbal. 1981. Abnormal fibrils from scrapie-infected brains. Acta Neurolpathol. (Berl.) 54: 63–74.
Merz, P. A., R. A. Somerville, and H. M. Wisniewski. 1983a. Abnormal fibrils in scrapie and senile dementia of the Alzheimer type. p. 259–281. InL. A. Court and F. Cathala (ed.), Virus non-conventionnels et affections du systeme nerveux central. Masson, Paris.
Merz, P. A., H. M. Wisniewski, R. A. Somerville, S. A. Bobin, K. Iqbal and C. L. Masters. 1983b. Ultrastruc- ture of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. (Berl.) 60: 113–124.
Merz, P. A., R. A* Somerville, H. M. Wisniewski, L. Manuelidis, and E. E. Manuelidis. 1983c. Scrapie associated fibrils in Creutzfeldt-Jakob disease. Nature 306: 474–476.
Merz, P. A., R. G. Rohwer, R. J. Kascsak, H. M. Wisniewski, R. A. Somerville, C. J. Gibbs, Jr., and D. C. Gajdusek. 1984a. Infection-specific particle from the unconventional slow virus diseases. Science 225: 437–440.
Merz, P. A., R. J. Kascsak, R. Rubenstein, R. I. Carp, and H. M. Wisniewski. 1984b. Variations in SAF from different scrapie agents, p. 137–145. InJ. Tateishi (ed.), Proceedings of Workshop on Slow Transmissible Diseases. Japanese Ministry of Health and Welfare, Tokyo.
Merz, P. A., R. J. Kascsak, N. K. Robakis, R. Rubenstein, and H. M. Wisniewski. 1986a. Recent studies on SAF. p. 91–94. InA. Bignami, L. Bolis, and D. C. Gajdusek (ed.), Discussions in neurosciences, Vol. 3. Fondation pour l’Etude du Systeme Nerveux Central et Peripheri- que, Amsterdam.
Merz, P. A., H. M. Wisniewski, R. Rubenstein, and R. J. Kascsak. 1986b. Immunological studies on paired helical filaments of Alzheimer’s disease, p. 58–68. InA. Bignami, L. Bolis, and D. C. Gajdusek (ed.), Discussions in Neurosciences, Vol. 3. Fondation pour l’Etude du Systeme Nerveux Central et Peripherique, Amsterdam.
Merz, P. A., R. J. Kascsak, R. Rubenstein, R. I. Carp, and H. M. Wisniewski. 1987a. Antisera to scrapie-associated fibril protein and prion protein decorate scrapie- associated fibrils. J. Virol. 61: 42–49.
Merz, P. A., R. J. Kascsak, N. Goller, R. Rubenstein, R. I. Carp, A. Vorbrodt, and H. M. Wisniewski. 1987b. Im- munocytochemistry of polyclonal and monoclonal antibodies to SAF polypeptides. (Submitted. )
Millson, G. C., and E. J. Manning. 1979. The effect of selected detergents on scrapie infectivity. p. 409–424. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 2. Academic Press, New York.
Millson, G. C., G. D. Hunter, and R. H. Kimberlin. 1971. An experimental examination of the scrapie agent in cell membrane mixtures. II. The association of scrapie activity with membrane fractions. J. Comp. Pathol. 81: 255–265.
Millson, G. C., G. D. Hunter, and R. H. Kimberlin. 1976. The physico-chemical nature of scrapie agent, p. 243–266. InR. H. Kimberlin (ed.), Slow virus diseases of animals and man. North-Holland, Amsterdam.
Mizutani, T., and H. Shiraki. (ed.). 1985. Clinicopatho- logical aspects of Creutzfeldt-Jakob disease. Elsevier, Amsterdam.
Mizutani, T., A. Okumura, M. Oda, and H. Shiraki. 1981. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J. Neurol. Neurosurg. Psychiatry 44: 103–115.
Moreau-Dubois, M. C., P. Brown, and D. C. Gajdusek. 1979. Comparisons of cell-fusing activity of brain suspensions from patients with Creutzfeldt-Jakob disease and other degenerative neurological diseases. Proc. Natl. Acad. Sci. USA 76: 5365–5367.
Morris, J. A., and D. C. Gajdusek. 1963. Encephalopathy in mice following inoculation of scrapie sheep brain. Nature 197: 1084–1086.
Mould, D. L., A. M. Dawson, and W. Smith. 1967. Determination of the dosage-response curve of mice inoculated with scrapie. J. Comp. Pathol. 77: 387–391.
Multhaup, G., H. Diringer, H. Helmert, H. Prinz, J. Heukeshoven, and K. Beyreuther. 1985. The protein component of scrapie-associated fibrils is a glycosylated low molecular weight protein. EMBO J. 4: 1495–1501.
Oesch, B., D. Westaway, M. Walchli, M. P. McKinley, S. B. Kent, R. Aebersold, R. A. Barry, A. Tempst, D. B. Teplow, L. E. Hand, S. B. Prusiner, and C. Weissmann. 1985. A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735–746.
Oleszak, E. L., L. Manuelidis, and E. E. Manuelidis. 1986. In vitro transformation elicited by Creutzfeldt-Jakob-infected brain material. J. Neuropathol. Exp. Neurol. 45: 489–502.
Oppenheimer, D. R. 1975. Pathology of transmissible and degenerative diseases of the nervous system, p. 161- 174. InL. S. Illis (ed.), Viral diseases of the central nervous system. Williams and Wilkins, Baltimore.
Outram, G. 1976. The pathogenesis of scrapie in mice. p. 325–357. InR. H. Kimberlin (ed.), Slow virus diseases of animals and man. North-Holland, Amsterdam.
Packer, R. J., D. R. Cornblath, N. K. Gonatas, L. A. Bruno, and A. K. Ashbury. 1980. Creutzfeldt-Jakob disease in a 20 year old woman. Neurology 30: 492–496.
Palsson, P. A. 1979. Rida (scrapie) in Iceland and its epidemiology. p. 357–366. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 1. Academic Press, New York.
Park, T. S., G. M. Kleinman, and E. P. Richardson. 1980. Creutzfeldt-Jakob disease with extensive degeneration of the white matter. Acta Neuropathol. (Berl.) 52: 239–242.
Parry, H. B. 1983. Scrapie disease in sheep. Academic Press, New York.
Patterson, I. H., M. N. Hoare, J. N. Jebben, and W. A. Watson. 1974. Further observations on the production of scrapie in sheep by oral dosing with foetal membranes from scrapie-affected sheep. Br. Vet. J. 130: 65–67.
Pritchard, J., V. Thadani, R. Kalb, and E. E. Manuelidis. 1987. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. Morbid. Mort. Weekly Rep. 36: 49–55.
Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144.
Prusiner, S. B. 1984a. Prions-novel infectious pathogens. Adv. Virus Res. 29: 1–56.
Prusiner, S. B. 1984b. Prions. Sci. Am. 251: 50–59.
Prusiner, S. B., and W. J. Hadlow (ed.). 1979. Slow transmissible diseases of the nervous system, Vols. 1 and 2. Academic Press, New York.
Prusiner, S. B., D. F. Groth, M. P. McKinley, S. P. Cochran, K. A. Bowman, and K. C. Kasper. 1981. Thiocya- nate and hydroxyl ions inactivate the scrapie agents. Proc. Natl. Acad. Sci. USA 78: 4606–4610.
Prusiner, S. B., M. P. McKinley, K. A. Bowman, D. C. Bolton, P. E. Bendheim, D. F. Groth, and G. G. Glenner. 1983. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35: 349–358.
Prusiner, S. B., D. F. Groth, D. C. Bolton, S. B. Kent, and L. E. Hand. 1984. Purification and structural studies of a major scrapie prion protein. Cell 38: 127–134.
Prusiner, S. B., R. Gabezin, and M. P. McKinley. On the biology of prions. Acta Neuropathol. (Berl) 72: 299–314; 1987.
Robakis, N. K., P. R. Sawh, G. C. Wolfe, R. Rubenstein, R. I. Carp, and M. A. Innis. 1986a. Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc. Natl. Acad. Sci. USA 83: 6377–6381.
Robakis, N. K., E. A. De vine-Gage, E. C. Jenkins, R. J. Kascsak, W. T. Brown, M. S. Krawczun, and W. P. Silverman. 1986b. Localization of a human gene homologous to the PrP gene in the p arm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochem. Biophys. Res. Commun. 140: 758–765.
Roberts, G. W., R. Lofthouse, R. Brown, T. J. Crow, R. A. Barry, and S. B. Prusiner. 1986. Prion protein immuno- reactivity in human transmissible dementias. N. Engl. J. Med. 315: 1231–1233.
Robertson, H. D., A. D. Branch, and J. E. Dahlberg. 1985. Focusing on the nature of the scrapie agent. Cell 40: 725–727.
Rohwer, R. G. 1983. Scrapie inactivation kinetics: an explanation for scrapie apparent resistance to inactivation, a reevaluation of estimates of its small size. p. 84–113. InL. A. Court and F. Cathala (ed.), Virus non conventionnels et affections du systeme nerveux central. Masson, Paris.
Rohwer, R. G. 1984a. Scrapie-associated fibrils. Lancet 2: 36.
Rohwer, R. G. 1984b. Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature 308: 658–662.
Rohwer, R. G. 1984c. Virus-like sensitivity of the scrapie agent to heat inactivation. Science 223: 600–602.
Rosenberg, R. N., C. L. White, P. Brown, D. C. Gajdusek, J. J. Volpe, J. Posner, and P. J. Dyck. 1986. Precautions in handling tissues, fluids and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Ann. Neurol. 19:75–77.
Rubenstein, R., R. I. Carp, and S. M. Callahan. 1984. In vitro replication of scrapie agent in a neuronal model: infection of PC 12 cells. J. Gen. Virol. 65: 2191–2198.
Rubenstein, R., R. J. Kascsak, P. A. Merz, M. C. Papini, R. I. Carp, N. K. Robakis, and H. M. Wisniewski. 1986. Detection of scrapie-associated fibril (SAF) proteins using anti-SAF antibody in non-purified tissue preparations. J. Gen. Virol. 67: 671–681.
Rubenstein, R., P. A. Merz, R. J. Kascsak, R. I. Carp, C. L. Scalici, C. L. Fama, and H. M. Wisniewski. 1987. Detection of scrapie associated fibrils (SAF) and SAF proteins from scrapie affected sheep. J. Infect. Dis. 156: 36–42.
Schoene, M. C., C. L. Masters, C. J. Gibbs, Jr., D. C. Gajdusek, H. R. Tyler, and G. J. Dammin. 1981. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease). Atypical clinical and pathological findings. Arch. Neurol. 38: 473–477.
Schumm, F., J. W. Boellaard, W. Schlote, and M. Stohr. 1981. Morbus Gerstmann-Straussler-Scheinker Familie Sch.—ein Bericht uber drei Kranke. Arch. Psychiatry Neurol. Sci. 230: 179–196.
Scott, J. R., and A. G. Dickinson. 1985. A view of dementia from the standpoint of unconventional infections. Gerontol Biomed. Acta 1: 127 - 150.
Seitelberger, F. 1962. Eigenartige familiar-hereditare Krankheit des Zentralnervensystems in eine neideros- terreichischen Sippe. (Zugleich ein Beitrag zur verglei- chenden Neuropathologie des Kuru.) Wiener Klin. Wo- chenschr. 74: 687–691.
Shinagawa, M., E. Munekata, S. Doe, K. Takahashi, H. Gato, and G. Sato. 1986. Immunoreactivity of a synthetic pentadecapeptide corresponding to the N-termi- nal region of the scrapie prion protein. J. Gen. Virol. 67: 1745–1750.
Sigurdsson, S. B. 1954. Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br. Vet. J. 110: 341–354.
Somerville, R. A., P. A. Merz, and R. I. Carp. 1986. Partial copurification of scrapie associated fibrils and scrapie infectivity. Intervirology 25: 48–55.
Sparkes, R. S., M. Simon, V. H. Cohn, R. E. K. Fournier, J. Lem, I. Klisak, C. Heinzmann, C. Blatt, M. Lucero, T. Mohandos, S. J. De Armond, D. Westaway, S. B. Prusiner, and L. P. Weiner. 1986. Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc. Natl. Acad. Sci. USA 83: 7358–7362.
Takahashi, K., M. Shinagawa, S. Doi, S. Sasaki, H. Goto, and G. Sato. 1986. Purification of scrapie agent from infected animal brains and raising of antibodies to the purified fraction. Microbiol. Immunol. 30: 123–131.
Tateishi, J., Y. Sato, M. Koga, M. Ohta, and Y. Kuroiwa. 1979. A transmissible variant of Creutzfeldt-Jakob disease with kuru plaques, p. 175–185. InS. B. Prusiner and W. J. Hadlow (ed.), Slow transmissible diseases of the nervous system, Vol. 2. Academic Press, New York.
Tateishi, J., H. Doi, Y. Sato, M. Suetsugu, K. Ishii, and Y. Kuroiwa. 1981. Experimental transmission of human subacute spongiform encephalopathy to small rodents. III. Further transmission from three patients and distribution patterns of lesions in mice. Acta Neuropathol. (Berl.) 53: 161–163.
Tateishi, J., Y. Sato, and M. Ohta. 1983. Creutzfeldt-Jakob disease in humans and laboratory animals, p. 195–221. InH. M. Zimmerman (ed.), Progress in neuropathology, Vol. 5. Raven Press, New York.
Tintner, R., P. Brown, E. T. Hedley-White, E. B. Rappaport, C. P. Piccardo, and D. C. Gajdusek. 1986. Neuropathologie verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications. Neurology 36: 932–936.
Towbin, H., T. Staehelin, and J. Gordon. 1979. Electropho- retic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350–4354.
Traub, R. D. 1983. Recent data and hypotheses on Creutz- feldt-Jakob disease. Adv. Neurol. 38: 149–164.
Vogt, O. 1925. Zur Pathoklisenlekie. Arch. Psychiatr. Ner- venki. 73: 740.
Ward, R. L., D. D. Porter, and J. G. Stevens. 1974. Nature of the scrapie agent: evidence against a viroid. J. Virol. 14: 1099–1103.
Weller, R. O., P. V. Steart, and J. D. Powell-Jackson. 1986. Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration. Neuropathol. Appl. Neurobiol. 12: 117–129.
Wells, G. A. H., A. C. Scott, C. T. Johnson, R. F. Gunning, R. D. Hancock, M. Jeffrey, M. Dawson, and R. Bradley. 1987. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121: 419–420.
Will, R. G., and W. B. Matthews. 1982. Evidence for case- to-case transmission of Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry 45: 235–238.
Will, R. G., W. B. Matthews, P. G. Smith, and C. Hudson. 1986. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–1979. II. Epidemiology. J. Neurol. Neurosurg. Psychiatry 49: 749 - 755.
Williams, E. S., and S. Young. 1980. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J. Wildl. Dis. 16: 89–98.
Williams, E. S., and S. Young. 1982. Spongiform encephalopathy of Rocky Mountain elk. J. Wildl. Dis. 18: 465–471.
Wilson, D. R., R. D. Anderson, and W. Smith. 1950. Studies in scrapie. J. Comp. Pathol. 60: 267–282.
Wisniewski, H. M., M. E. Bruce, and H. Fraser. 1975. Infectious etiology of neuritic (senile) plaques in mice. Science 190: 1108–1109.
Wisniewski, H. M., R. C. Moretz, and A. S. Lossinsky. 1981. Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann. Neurol. 10: 517–522.
Wisniewski, H. M., G. S. Merz, P. A. Merz, G. Y. Wen, and K. Iqbal. 1983. Neurofibrillary tangles and paired helical filaments in Alzheimer’s disease, p. 196–221. InC. A. Marrota (ed.), Neurofilaments. University of Minnesota Press, Minneapolis.
Wisniewski, H. M., K. Iqbal, I. Grundke-Iqbal, R. Rubenstein, G. Y. Wen, P. A. Merz, R. Kascsak, and K. Kristensson. 1986. Amyloid in Alzheimer’s disease and unconventional viral infections. Int. Symp. Dementia Amyloid Neuropathol. Suppl. 3: 87–94.
Wu, Y., W. T. Brown, N. K. Robakis, C. Dobkin, E. Divine-Gage, P. A. Merz, and H. M. Wisniewski. 1987. A Pvu II. RFLP detected in the human prion protein (PrP) gene. Nucleic Acids Res. 15: 3191.
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Merz, P.A., Wisniewski, H.M. (1988). Unclassified: Spongiform Encephalopathies. In: Laboratory Diagnosis of Infectious Diseases Principles and Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3900-0_42
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3900-0_42
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8394-2
Online ISBN: 978-1-4612-3900-0
eBook Packages: Springer Book Archive